ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Impact of Literacy Level on Patient Education and Health Among People With Arthritis

This study is currently recruiting patients.

Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

People with poor literacy may have worse health and less knowledge about how to manage their disease than patients at high reading levels. Patients with arthritis usually receive information on how to manage their disease that is written at an 11th grade reading level. The purpose of this study is to compare the health outcomes of patients with arthritis given either standard 11th grade level materials or interactive, in-person arthritis education along with materials written at a lower reading level.

Condition Treatment or Intervention Phase
Rheumatoid Arthritis
Psoriatic Arthritis
Polyarthritis
 Behavior: 11th grade reading level arthritis materials
 Behavior: Interactive in-person arthritis education
Phase II

MedlinePlus related topics:  Arthritis;   Rheumatoid Arthritis

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study

Official Title: Literacy in Arthritis Management: A Randomized Controlled Clinical Trial of a Novel Education Intervention

Further Study Details: 

Expected Total Enrollment:  100

Study start: November 2002

Patients with poor literacy report worse health and know less about managing their disease than patients with better literacy. This study will compare the disease outcomes of arthritis patients at three different reading levels who receive either standard arthritis materials written at an 11th grade reading level or an in-person, interactive, text-free session along with lower reading level materials. The study will determine the most effective methods of educating patients with poor literacy about their disease.

Patients with systemic inflammatory rheumatic conditions (rheumatoid arthritis, psoriatic arthritis, and seronegative polyarthritis) will be assessed and placed into one of three reading levels: 8th grade or lower; 9th to 11th grade; or 12th grade or higher. Patients from each reading level will be randomly assigned to one of two intervention groups. Group 1 will receive disease-specific material from the Arthritis Foundation written at an 11th grade reading level. Group 2 will receive plain language materials, an arthritis glossary, and a one-hour, in-person session with a study educator using interactive, text-free methods. The study educator will help the patient with reading-related problems either by study visit or by telephone for 6 months postsession.

All patients will receive a medication calendar. Patients will be followed for one year after the intervention and will be assessed for changes in health status, disease activity, communication with the physician, self-management of their arthritis, understanding of and adherence to prescribed treatment, and satisfaction with their intervention.

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:


Location and Contact Information


Massachusetts
      Brigham and Women's Hospital, Boston,  Massachusetts,  02115,  United States; Recruiting
Matthew H. Liang, MD, MPH  617-732-5505    mliang@partners.org 
Victoria Gall, PT, MEd  617-732-5080    vgall@rics.bwh.harvard.edu 
Matthew H. Liang, MD, MPH,  Principal Investigator

Study chairs or principal investigators

Matthew H. Liang, MD, MPH,  Principal Investigator,  Brigham and Women's Hospital   

More Information

Publications

Weiss BD, Hart G, McGee DL, D'Estelle S. Health status of illiterate adults: relation between literacy and health status among persons with low literacy skills. J Am Board Fam Pract. 1992 May-Jun;5(3):257-64.

Study ID Numbers:  NIAMS-068; P60 AR47782
Record last reviewed:  September 2004
Record first received:  August 29, 2001
ClinicalTrials.gov Identifier:  NCT00023205
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act